The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

(Reuters) -Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion. Shares of the ...

President Trump’s long-promised trade war could start as soon as Saturday, leaving companies scrambling for a workaround for ...

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

The Company has added an Australian entity, Max Brazil, to hold the "Florália DSO Project" through the existing Canadian and Brazilian holding entities. As announced on January 9, 2025, Max Brazil ...

Sources privy to the development said that the company is actively streamlining its operations to address various challenges ...

Earn 2 miles per dollar spent on most purchases, and receive a slew of travel-related perks, including airport lounge access.

Private equity will have a more positive 2025 than it's had recent years, and institutional investors will likely turn their ...

(Alliance News) - The struggling public market in London got a small, but much-needed, vote of confidence on Friday, as Cardiogeni PLC started trading on Aquis Stock Exchange, while RC Fornax PLC ...

MicroStrategy sold 7.3 million shares of 8% Series A perpetual strike preferred stock to raise $563.4 million, which the ...